Novo Nordisk, a global healthcare company, announced that the European Commission has granted an extension of the indication for Fiasp (fast─acting insulin aspart), approving it for the treatment of diabetes in

Therapeutic Protein Combo Fast Tracked for CDI Treatment The Food and Drug Administration (FDA) has granted Fast Track designation to LMN-201 for the treatment and prevention of Clostridioides difficile infection (CDI)...

De goedkeuring onlangs door de FDA van resmetirom betekent dat er een betrekkelijk effectief middel beschikbaar komt voor de behandeling van niet-alcoholische leverontsteking (NASH). Die goedkeuring is opmerkelijk omdat...

Akcea’s FDA-rejected Waylivra also recommended The EMA’s main advisory committee for medicines backed new indications for AstraZeneca and Merck & Co/MSD’s Lynparza and Sanofi’s Dupixent that could both unlock...